Does presence of hematologic malignancy change our approach to non-small cell lung cancer?

Ann Thorac Surg. 2011 May;91(5):1652-3; author reply 1653. doi: 10.1016/j.athoracsur.2010.12.027.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / epidemiology*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Cohort Studies
  • Comorbidity
  • Disease-Free Survival
  • Female
  • Hematologic Neoplasms / epidemiology*
  • Hematologic Neoplasms / pathology
  • Hematologic Neoplasms / therapy
  • Humans
  • Lung Neoplasms / epidemiology*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Male
  • Pneumonectomy / methods
  • Pneumonectomy / mortality
  • Postoperative Complications / mortality
  • Postoperative Complications / physiopathology
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome